Clinical Trials Directory

Trials / Sponsors / Navidea Biopharmaceuticals

Navidea Biopharmaceuticals

Industry · 19 registered clinical trials.

StatusTrialPhaseStarted
TerminatedTc 99m Tilmanocept Imaging for Early Prediction of Anti-TNFα Therapy Response in Moderate to Severe Active RA
Rheumatoid Arthritis
Phase 32022-03-02
TerminatedComparison of Tc 99m Tilmanocept Imaging With IHC Analysis of CD206 Expression in Synovial Tissue of Subjects
Rheumatoid Arthritis
Phase 22021-09-14
CompletedDevelopment of a Normative Database for Rheumatoid Arthritis (RA) Imaging With Tc99m Tilmanocept
Rheumatoid Arthritis
Phase 22021-05-27
CompletedEvaluation of the Precision and Sensitivity of Tilmanocept Uptake Value (TUV) on Tc 99m Tilmanocept Planar Ima
Rheumatoid Arthritis
Phase 22019-04-08
TerminatedSafety Evaluation of IV Tc 99m Tilmanocept and Comparison of Imaging With Sulfur Colloid in Subjects With and
Nonalcoholic Steatohepatitis, NASH - Nonalcoholic Steatohepatitis
Phase 12017-12-06
CompletedAn Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS)
Kaposi Sarcoma, HIV Infections
Phase 12017-12-01
WithdrawnPharmacokinetics and Dosimetry of Tc 99m Tilmanocept Following a Single Intravenous Dose Administration in Mal
Arthritis, Rheumatoid
Phase 12017-09-01
TerminatedAn Evaluation of Tilmanocept by IV Injection Using SPECT/CT vs PET Imaging in Subjects With Liver Metastases.
Liver Metastases, Colorectal Carcinoma
Phase 12017-07-26
WithdrawnA Cross-Over, Multi-Center Trial to Evaluate the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging
Parkinson's Syndrome
Phase 32017-04-01
CompletedEvaluating Safety of Escalating Doses of Tilmanocept by IV Injection and SPECT Imaging in Subjects With and Wi
Arthritis, Rheumatoid
Phase 1 / Phase 22017-01-01
CompletedEvaluation of SC Injected Tc 99m Tilmanocept Localization in Active RA Subjects by SPECT and SPECT/CT Imaging
Rheumatoid Arthritis
Phase 12016-07-01
CompletedEvaluation of Tc 99m Tilmanocept Localization in Primary Cutaneous Kaposi's Sarcoma and Lymphatic Drainage by
Kaposi's Sarcoma
Phase 22014-09-01
TerminatedEvaluation of the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis
Parkinson's Syndrome
Phase 32013-11-01
UnknownA Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Bet
Dementia, Alzheimer's Disease
Phase 32013-06-01
TerminatedBeta-Amyloid Imaging With [18F]NAV4694 PET in Predicting Progression to AD in Subjects MCI
Mild Cognitive Impairment
Phase 22013-03-01
UnknownEfficacy and Safety of the PET Imaging Agent [18F]NAV4694 in Subjects With Probable Alzheimer's Disease
Alzheimer Disease
Phase 22012-08-01
CompletedBreast and Melanoma Trial With Lymphoseek to Identify Lymph Nodes
Breast Cancer, Melanoma
Phase 32010-06-01
TerminatedEvaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma (HNSCC)
Phase 32009-05-01
CompletedTrial of Lymphoseek in Intraoperative Localization of Lymph Nodes in Breast Cancer and Melanoma
Breast Cancer, Melanoma
Phase 32008-04-01